Skip Navigation LinksHome > December 2012 - Volume 18 - Issue > TOUCH® Patient Reported Outcomes Study: The Impact of Natali...
Inflammatory Bowel Diseases:
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations

TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Crohn's Disease Severity: P‐63

Lewis, James1; Nag, Arpita2; Taylor, Lori3; Hogge, Gary4; Colombel, Jean‐Frédéric5; Kane, Sunanda6; Panaccione, Remo7; Rubin, David8

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login